ADVENTRX (ANX:AMEX) is a biopharmaceutical research and development company focused on commercializing low development risk pharmaceuticals for cancer and infectious disease that enhance the efficacy and/or safety of existing therapies. Successfully led company through first year of SOX 404 compliance On-going SEC Reporting requirements Implementation and use of Great Plains accounting software including project module for R&D projects Manage all general accounting functions with a staff of 2 Treasury management for $60 million portfolio Acting CFO second half of 2006.  Assisted with 2 rounds of financing including a $40 million registered direct

NuVasive Inc. (NUVA) NuVasive is a medical device company focusing on the design, development and marketing of products for use in minimally disruptive surgical treatments for the spine. NuVasive successfully completed an IPO in May of 2004 raising $71.5 million. Lead accounting department with staff of 5 Participated in all aspects of IPO completed in May 2004 Responsible for ongoing SEC Reporting requirements Manage and coordinate stock option administration Kick-off and management of sales tax compliance project Tax compliance and coordination with service providers Manage and coordinate audits and reviews Team leader for Sarbanes Oxley 404 implementation Treasury management for $60 million portfolio

Websense Inc. (WBSN) provides employee Internet management products that enable businesses to monitor, report and manage how their employees use the Internet. Websense successfully completed an IPO in March of 2000, which raised $72 million. Lead role in IPO completed in March of 2000 Lead and managed accounting staff of 6 Substantial participation in planning for and establishment of international headquarters in Ireland Responsible for internal management and BOD reporting SEC reporting and compliance Tax compliance including sales tax compliance project Treasury management for $80 million portfolio Managed and coordinated audits and reviews